deaths (OS)

laHNSCC - 1st line (L1) locally advanced (laHNSCC) laHNSCC - 1st line (L1)

versus placebo
avelumab alone vs. placebo 1 1.31 [0.93; 1.85], 1 RCT, I2=0%
inconclusive result